Sterile Injectables Market Size to Witness Huge Growth by 2025

Analyst Speak:

The Global Sterile Injectables Market was valued around US$ 385.9 Bn by 2018 and growing at a CAGR of 12.4% over next seven years 2019-2025 due to increasing occurrence of cancer across the globe”.  

The global sterile injectables market accounted for US$ 385.9 Bn in 2018 and burgeoning over the forthcoming years. Some of the key factors influencing the market growth include increasing occurrence of cancer across the globe, growing use of biologics in healthcare industry and rising R&D focus on development of biotechnology-engineered anti-cancer drugs, changing lifestyle and rising demand for the better quality of life. However, high expenses associated with inventory management and severe government regulations are the major factors inhibiting the market growth. 

Global sterile injectables market segmented on the basis of molecule type, drug type, disease indication, route of administration, distribution channel and region. 

Avail Sample Report of the Market @

Monoclonal Antibodies dominate the Global Sterile Injectables Market

Based on drug type, global sterile injectables market is monoclonal antibodies, cytokines, insulin, peptide hormones, blood factors, vaccines, immunoglobulins, peptide antibiotics and others. Monoclonal Antibodies held considerable market growth during estimated period. Monoclonal antibodies are identical immunoglobulins, generated from a single B-cell clone. These antibodies recognize unique epitopes, or binding sites, on a single antigen. They identify and bind to antigens in order to distinguish between specific epitopes which offers protection against disease organisms. 

They target numerous proteins that impact cell activity such as receptors or other proteins present on the surface of normal and cancer cells. The specificity of monoclonal antibodies permits its binding to cancerous cells by pairing a cytotoxic agent such as a strong radioactive which then seek outs to destroy the cancer cells while not harming the healthy ones. 

North America Leads the Global Sterile Injectables market 

PBI’s global sterile injectables market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis. North America accounted for larger revenue share in global sterile injectables market with considerable CAGR. The growth in this region can be attributed to increase in spending’s on research and development, expansion of various companies to increase their production capacities and rising acceptance of oncology-related drugs in hospitals. In addition, Asia Pacific held significant market share during estimated period owing to rising awareness about sterile injectable drugs and different types of rules imposed in the region by several government bodies. 

Strategic Acquisitions are the Key Strategies Adopted by Market Players 

Global sterile injectables market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. In 2015 Pfizer Inc. acquired Hospira, Inc., world’s leading provider of injectable and infusion technologies. 

Key player’s profiles in the report are AbbVie Inc. (U.S), Amgen Inc. (U.S), AstraZeneca plc (U.K), Baxter International Inc. (U.S), Eli Lilly and Company (U.S), GILEAD SCIENCES, INC. (U.S), GlaxoSmithKline plc. (U.K), Johnson & Johnson Services, Inc. (U.S), Merck & Co., Inc. (U.S), Novo Nordisk A/S (Denmark), Novartis AG (Switzerland), Pfizer Inc. (U.S), F. Hoffmann-La Roche AG (Switzerland) and Sanofi (France). 

Precision Business Insights (PBI) in its report titled “Global Sterile Injectables Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Moreover, the report also includes the total revenue and volume for the market. 

For More Information @

Detailed Segmentation 

By Molecule Type                          

  • Large Molecules
  • Small Molecules


By Drug Type                    

  • Monoclonal Antibodies
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Vaccines
  • Immunoglobulins
  • Peptide Antibiotics
  • Others


By Disease Indication                   

  • Cancer
  • Diabetes
  • Cardiovascular Diseases
  • Musculoskeletal
  • CNS
  • Infections
  • Others


 By Route of Administration                      

  • Intravenous (IV)
  • Intramuscular (IM)
  • Subcutaneous (SC)
  • Others


By Distribution Channel                              

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies                


By Geography

North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


About Us:
Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.
Contact Us:
Shreya Paul
Senior Business Development Executive
Email @
Call @ +1-866-598-1553
Precision Business Insights